Abstract
Polycystic ovary syndrome (PCOS) is one of the most common metabolism and endocrine disorder affecting women of reproductive age. However, the genetic mechanisms of PCOS remain largely elusive. A transcriptome-wide association study(TWAS) was conducted to identify the genes associated with PCOS using gene expression references of the whole blood and ovary. Then mRNA expression profiling analysis was performed to identify common genes with TWAS. Genes detected by TWAS were subjected to Gene Ontology(GO), pathway enrichment and protein-protein analysis. TWAS identified 422 genes for the whole blood and 177 genes for ovary, such as EML6 (TWAS.P = 6.33E-05), GRAP (TWAS.P = 0.000211), MAFTRR(TWAS.P = 1.21E-05). Functional enrichment analysis detected biological processes including ncRNA metabolic process, microtubule-related pathways. The present study identified a number of potential PCOS genes and biological processes. These results may provide insight into the genetic basis of PCOS.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
National Natural Science Foundation, Grant/Award Number: 81974124
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://www.repository.cam.ac.uk/handle/1810/283491
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.